These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27469148)

  • 1. The role of the Kidney Foundation of Bangladesh in promoting kidney care in a resource-limited environment.
    Rashid HU; Arefin S; Hasan S; Alam K
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):64-68. PubMed ID: 27469148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of renal replacement therapies in Finland.
    Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
    Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal care in developing countries: the India experience.
    Jha V
    Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease in Paraguay.
    Santa Cruz F; Cabrera W; Barreto S; Mayor MM; Báez D
    Kidney Int Suppl; 2005 Aug; (97):S120-5. PubMed ID: 16014089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of kidney care in countries with limited resources: How does the National Kidney Foundation of South Africa fare?
    Meyers AM
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):69-73. PubMed ID: 27469152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
    Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost analysis of kidney replacement therapy options in Palestine.
    Younis M; Jabr S; Al-Khatib A; Forgione D; Hartmann M; Kisa A
    Inquiry; 2015; 52():. PubMed ID: 25765018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of kidney foundations in alleviating the burden of CKD in India - an example, Tamilnad Kidney Research Foundation.
    Abraham G; Vijayan M; Ravi R; Kumaraswami L; Venkatesan M
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):74-77. PubMed ID: 27469149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription and practice of dialysis in Australia, 1988.
    Disney AP
    Am J Kidney Dis; 1990 May; 15(5):494-9. PubMed ID: 2333870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.